1h Free Analyst Time
The infectious disease market is poised to grow by $104.81 billion during 2023-2027, accelerating at a CAGR of 12.49% during the forecast period. The market is driven by the increasing prevalence of infectious diseases, growing awareness of infectious diseases, and a strong drug pipeline.Speak directly to the analyst to clarify any post sales queries you may have.
This report on the infectious disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment.
The infectious disease market is segmented as below:
By Product
- Drugs
- Vaccines
By End-user
- Hospital
- Multispecialty clinic
- Others
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This report on the infectious disease market covers the following areas:
- Infectious disease market sizing
- Infectious disease market forecast
- Infectious disease market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Executive Summary
The analyst recognizes the following companies as the key players in the global infectious disease market: Bio Rad Laboratories Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Trinity Biotech Plc, Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, DiaSorin SpA, Quidel Corp., and Thermo Fisher Scientific Inc.Commenting on the report, one of the report's analysts said: 'The latest trend gaining momentum in the market is the development of novel drugs.'
According to the report, one of the major drivers for this market is the increasing prevalence of infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bio Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- Genetic Signatures Ltd.
- Grifols SA
- Hologic Inc.
- Meridian Bioscience Inc.
- Meril Life Sciences Pvt. Ltd.
- OraSure Technologies Inc.
- PerkinElmer Inc.
- QIAGEN NV
- Siemens AG
- Sysmex Corp.
- Trinity Biotech Plc
- Abbott Laboratories
- Becton Dickinson and Co.
- bioMerieux SA
- DiaSorin SpA
- Quidel Corp.
- Thermo Fisher Scientific Inc.
